68 related articles for article (PubMed ID: 32730143)
1. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China.
Fan S; Liu M; Bai L; Chen S; Hou B; Lin N; Yuan J; Mao C; Niu J; Ren H; Zhao Y; Zhang Z; Zhu Y; Peng B; Guan H
J Neurovirol; 2023 Dec; 29(6):692-698. PubMed ID: 37898569
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy in patients with chronic liver disease successfully treated with pembrolizumab.
Jeantin L; Shor N; Coustans M; Roos-Weil D; Quintin-Roué I; Bellanger A; Le Garff-Tavernier M; Ben Jemaa R; Thabut D; Pourcher V; Weiss N
J Neurol; 2024 Apr; 271(4):2119-2124. PubMed ID: 38143261
[No Abstract] [Full Text] [Related]
3. Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim.
Lombardo-Del Toro P; Bragado-Trigo I; Arroyo P; Tena-Cucala R; Bau L; Matas E; Muñoz-Vendrell A; Simó M; Pons-Escoda A; Martínez-Yélamos A; Martínez-Yélamos S; Romero-Pinel L
J Neurol; 2023 Nov; 270(11):5196-5200. PubMed ID: 37460853
[No Abstract] [Full Text] [Related]
4. Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod.
Jeantin L; Shor N; Pallix-Guyot M; Roos-Weil D; Bellanger A; Le Garff-Tavernier M; Papeix C; Weiss N; Pourcher V
J Neurol; 2024 Feb; 271(2):729-732. PubMed ID: 37910249
[No Abstract] [Full Text] [Related]
5. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.
Cortese I; Reich DS; Nath A
Nat Rev Neurol; 2021 Jan; 17(1):37-51. PubMed ID: 33219338
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?
Roos-Weil D; Weiss N; Guihot A; Uzunov M; Bellanger A; Eymard B; Saadoun D; Houillier C; Idbaih A; Demeret S; Deback C; Leblond V; Galanaud D; Shor N; Pourcher V
J Neurol; 2021 Jul; 268(7):2458-2465. PubMed ID: 33515299
[TBL] [Abstract][Full Text] [Related]
7. Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions.
Atkinson AL; Atwood WJ
Viruses; 2020 Sep; 12(9):. PubMed ID: 32882975
[TBL] [Abstract][Full Text] [Related]
8. Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy.
Patel A; Sul J; Gordon ML; Steinklein J; Sanguinetti S; Pramanik B; Purohit D; Haroutunian V; Williamson A; Koralnik I; Harel A
JAMA Neurol; 2021 Jun; 78(6):736-740. PubMed ID: 33724354
[TBL] [Abstract][Full Text] [Related]
9. Late occurrence of progressive multifocal leukoencephalopathy after anti-CD19 chimeric antigen receptor T-cell therapy.
Mian A; Andrapalliyal N; Weathers AL; Pohlman B; Hill BT
Eur J Haematol; 2021 Apr; 106(4):584-588. PubMed ID: 33459429
[TBL] [Abstract][Full Text] [Related]
10. TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer.
Strassl I; Windhager A; Machherndl-Spandl S; Buxhofer-Ausch V; Stiefel O; Weltermann A
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7113-7123. PubMed ID: 36877279
[TBL] [Abstract][Full Text] [Related]
11. Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV.
Pinnetti C; Cimini E; Vergori A; Mazzotta V; Grassi G; Mondi A; Forbici F; Amendola A; Grisetti S; Baldini F; Candela C; Casetti R; Campioni P; Capobianchi MR; Agrati C; Antinori A
Viruses; 2022 May; 14(5):. PubMed ID: 35632711
[TBL] [Abstract][Full Text] [Related]
12. Novel treatments for progressive multifocal leukoencephalopathy.
Bennett KM; Fernandes PM
Br J Hosp Med (Lond); 2020 Jul; 81(7):1-9. PubMed ID: 32730143
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy.
Medrano C; Vergez F; Mengelle C; Faguer S; Kamar N; Del Bello A
Emerg Infect Dis; 2019 Nov; 25(11):2145-2147. PubMed ID: 31625858
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
Holmes A; Wellings T; Walsh O; Rowlings P
J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
[TBL] [Abstract][Full Text] [Related]
15. Progressive multifocal leukoencephalopathy treated with nivolumab.
Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
[TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab.
Varmpompiti K; Westwood AJ; Ben-Joseph A; Sibtain N; Ibrahim MAA; Stanton B; Zuckerman M; Hadden R; Ritter LM
J Neuroimmunol; 2023 Dec; 385():578248. PubMed ID: 37995595
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
